Arca Biopharma reported $0 in Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Amgen AMGN:US $ 36522M 332M
Arca Biopharma ABIO:US $ 0M 0M
Biogen BIIB:US $ 7277.2M 2M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Cytokinetics CYTK:US $ 199.42M 1.44M
Cytrx CYTR:US 0 0
Daiichi Sankyo 4568:JP Y 163367M 94M
GlaxoSmithKline GSK:LN 2211100M 1121700M
Laboratory Of America LH:US $ 5454.3M 24.2M
Otsuka Holdings 4578:JP Y 209034M 2839M
United Therapeutics UTHR:US $ 800M 0M